Hemophagocytic Lymphohistiocytosis in a Patient With COVID-19 Hemophagocytic Lymphohistiocytosis in a Patient With COVID-19

This patient with hemophagocytic lymphohistiocytosis secondary to COVID-19 responded after one dose of the IL-6 receptor antagonist tocilizumab.Journal of Medical Case Reports
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Family Medicine/Primary Care Journal Article Source Type: news